E488 | This Week in European Tech with Dan, Mads & Lomax

Welcome to a new episode of the EUVC podcast, where and of and from gather to unpack the macro forces and micro signals shaping European tech and venture.This week, the trio dive into:Why Europe’s fiscal firepower could be its unfair advantageThe growing exodus of IPOs from the UK to the USStrategic defense investment—can the UK move the needle?How AI and capital markets are collidingAnd yes, we close on psychedelics and patient-first biotech breakthroughsHere's what’s covered:02:15 Europe’s Fiscal Advantage: Why Better Balance Sheets Matter for Innovation07:00 The Return of Low Rates: What It Means for Startups11:20 London vs. New York: The IPO Drain17:00 Why Capital Leaves: Liquidity, Coverage & the Search for Growth21:30 Rebuilding the UK Market: The Case for LP Allocation Reform25:50 Beyond IPOs: The Full-Stack Capital Problem30:40 AI and Lawsuits: Welcome to the New Frontier33:10 Defense Tech Heats Up: Drones, AI & Strategic Capital38:40 Can the UK Compete? Global Arms Races & National Reviews42:30 Liquid Biopsies & Healthcare Breakthroughs46:20 NHS Efficiency Crisis: More Money, Worse Outcomes50:30 Psychedelics on the Edge: Awaiting the Data Drop

There are no comments yet.

Please log in to write the first comment.